Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Optimization of Chromatographic Parameters – V 2.0

Posted on By

Analytical Method Development: SOP for Optimization of Chromatographic Parameters – V 2.0

Standard Operating Procedure for Optimization of Chromatographic Parameters in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/364/2025
Supersedes SOP/AMD/364/2022
Page No. Page 1 of 13
Issue Date 01/06/2025
Effective Date 04/06/2025
Review Date 01/06/2027

1. Purpose

To establish a comprehensive and systematic approach for optimizing chromatographic parameters during the development of analytical methods, specifically HPLC and GC, ensuring precise, accurate, and reproducible results.

2.

Scope

This SOP applies to all method development activities involving chromatographic techniques—High Performance Liquid Chromatography (HPLC) and Gas Chromatography (GC)—carried out in the Analytical Method Development department for API and formulation samples.

3. Responsibilities

  • Analytical Scientist: Conducts chromatographic optimization trials and documents results.
  • Method Development Lead: Reviews system suitability and performance data to finalize parameters.
  • QA Reviewer: Verifies data integrity and ensures compliance with regulatory and internal standards.

4. Accountability

The Head of Analytical Method Development is accountable for ensuring that the optimization process is executed, verified, and documented in alignment with ICH Q2(R1), regulatory guidelines, and internal quality policies.

5. Procedure

5.1 Preliminary Setup

  1. Gather physicochemical properties of analyte: pKa, solubility, polarity, logP, UV absorbance, boiling point (for GC).
  2. Select appropriate column based on analyte characteristics:
    • HPLC: C18, C8, Phenyl, or HILIC based on polarity and retention needs
    • GC: Capillary column (e.g., DB-1, DB-5, FFAP) based on volatility and separation profile

5.2 Mobile Phase and Diluent Selection

  1. Choose solvent system (e.g., water:acetonitrile, water:methanol) compatible with analyte solubility and detector requirements.
  2. Adjust pH to influence ionization state and retention behavior; use buffer systems like phosphate, acetate, or ammonium formate.
  3. Ensure diluent compatibility with both sample and mobile phase to avoid precipitation or baseline drift.

5.3 Flow Rate Optimization

  1. Begin trials at standard flow rate (e.g., 1.0 mL/min for HPLC).
  2. Assess retention time, peak symmetry, and resolution under increased and decreased flow conditions.
  3. Select flow rate that ensures optimal separation and system pressure compliance.

5.4 Column Temperature

  1. Study effect of temperature (e.g., 25°C to 45°C) on peak shape, tailing, and baseline noise.
  2. Maintain consistent oven temperature for GC methods to ensure reproducibility.

5.5 Detection Parameters

  1. HPLC: Select detection wavelength based on analyte’s UV absorbance maximum using UV scan data.
  2. GC: Use Flame Ionization Detector (FID) or Thermal Conductivity Detector (TCD) depending on sensitivity and compound class.

5.6 Injection Volume and Sample Load

  1. Optimize injection volume (typically 10–20 µL for HPLC) to balance sensitivity and peak shape.
  2. Avoid column overloading and ensure linearity within working concentration range.

5.7 System Suitability and Repeatability

  1. Evaluate system suitability parameters:
    • Theoretical plates (N)
    • Tailing factor (Tf)
    • Resolution (Rs)
    • Retention time (Rt)
  2. Repeat test for minimum six injections to ensure reproducibility.

5.8 Documentation

  1. Record all optimization trials, observations, and decisions in Annexure-1.
  2. Attach chromatograms, UV scans, and system suitability reports.
  3. Summarize the finalized parameters in Annexure-2.

6. Abbreviations

  • HPLC: High Performance Liquid Chromatography
  • GC: Gas Chromatography
  • FID: Flame Ionization Detector
  • UV: Ultraviolet
  • LOD: Limit of Detection
  • Rt: Retention Time

7. Documents

  1. Annexure-1: Optimization Trial Log
  2. Annexure-2: Finalized Chromatographic Parameters Summary

8. References

  • ICH Q2(R1): Validation of Analytical Procedures
  • USP General Chapters <621> and <1021>
  • FDA Guidance on Analytical Procedure Development

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Aarti Sharma Rakesh Verma Dr. Manish Dubey
Designation Analytical Scientist QA Reviewer Head – AMD
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: Optimization Trial Log

Trial No. Parameter Modified Value Observation Conclusion
1 Flow Rate 0.8 mL/min Better resolution but longer runtime Not selected
2 Mobile Phase ACN:Buffer (60:40) Sharp peaks and symmetry Selected

Annexure-2: Finalized Chromatographic Parameters Summary

  • Column: C18, 150 mm × 4.6 mm, 5 µm
  • Mobile Phase: Acetonitrile:Phosphate buffer (60:40, v/v)
  • Flow Rate: 1.0 mL/min
  • Detection Wavelength: 254 nm
  • Injection Volume: 10 µL
  • Run Time: 10 min

Revision History

Revision Date Revision No. Description Reason Approved By
01/06/2025 2.0 Updated trial formats and buffer selection criteria Annual Review Dr. Manish Dubey
15/08/2022 1.0 Initial SOP Release New SOP QA Head
See also  Analytical Method Development: Analytical Control Strategy Development - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Analytical Method Development: SOP for Selection of Analytical Techniques – V 2.0
Next Post: Analytical Method Development: SOP for Linearity and Range Evaluation – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version